2024-04-01 2025-03-31 2025-03-31 false SC652609 RA MEDIC LTD 2025-12-24 86220 false iso4217:GBP xbrli:pure SC652609 2024-03-31 SC652609 2025-03-31 SC652609 2024-04-01 2025-03-31 SC652609 2023-03-31 SC652609 2024-03-31 SC652609 2023-04-01 2024-03-31 SC652609 bus:SmallEntities 2024-04-01 2025-03-31 SC652609 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 SC652609 bus:FullAccounts 2024-04-01 2025-03-31 SC652609 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC652609 core:WithinOneYear 2025-03-31 SC652609 core:AfterOneYear 2025-03-31 SC652609 core:WithinOneYear 2024-03-31 SC652609 core:AfterOneYear 2024-03-31 SC652609 core:ShareCapital 2025-03-31 SC652609 core:SharePremium 2025-03-31 SC652609 core:RevaluationReserve 2025-03-31 SC652609 core:OtherReservesSubtotal 2025-03-31 SC652609 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC652609 core:ShareCapital 2024-03-31 SC652609 core:SharePremium 2024-03-31 SC652609 core:RevaluationReserve 2024-03-31 SC652609 core:OtherReservesSubtotal 2024-03-31 SC652609 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC652609 core:LandBuildings 2025-03-31 SC652609 core:PlantMachinery 2025-03-31 SC652609 core:Vehicles 2025-03-31 SC652609 core:FurnitureFittings 2025-03-31 SC652609 core:OfficeEquipment 2025-03-31 SC652609 core:NetGoodwill 2025-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 SC652609 core:ListedExchangeTraded 2025-03-31 SC652609 core:UnlistedNon-exchangeTraded 2025-03-31 SC652609 core:LandBuildings 2024-03-31 SC652609 core:PlantMachinery 2024-03-31 SC652609 core:Vehicles 2024-03-31 SC652609 core:FurnitureFittings 2024-03-31 SC652609 core:OfficeEquipment 2024-03-31 SC652609 core:NetGoodwill 2024-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 SC652609 core:ListedExchangeTraded 2024-03-31 SC652609 core:UnlistedNon-exchangeTraded 2024-03-31 SC652609 core:LandBuildings 2024-04-01 2025-03-31 SC652609 core:PlantMachinery 2024-04-01 2025-03-31 SC652609 core:Vehicles 2024-04-01 2025-03-31 SC652609 core:FurnitureFittings 2024-04-01 2025-03-31 SC652609 core:OfficeEquipment 2024-04-01 2025-03-31 SC652609 core:NetGoodwill 2024-04-01 2025-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 SC652609 core:ListedExchangeTraded 2024-04-01 2025-03-31 SC652609 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 SC652609 core:MoreThanFiveYears 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments 2025-03-31 SC652609 core:Non-currentFinancialInstruments 2024-03-31 SC652609 dpl:CostSales 2024-04-01 2025-03-31 SC652609 dpl:DistributionCosts 2024-04-01 2025-03-31 SC652609 core:LandBuildings 2024-04-01 2025-03-31 SC652609 core:PlantMachinery 2024-04-01 2025-03-31 SC652609 core:Vehicles 2024-04-01 2025-03-31 SC652609 core:FurnitureFittings 2024-04-01 2025-03-31 SC652609 core:OfficeEquipment 2024-04-01 2025-03-31 SC652609 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 SC652609 core:NetGoodwill 2024-04-01 2025-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 SC652609 dpl:GroupUndertakings 2024-04-01 2025-03-31 SC652609 dpl:ParticipatingInterests 2024-04-01 2025-03-31 SC652609 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 SC652609 core:ListedExchangeTraded 2024-04-01 2025-03-31 SC652609 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 SC652609 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 SC652609 dpl:CostSales 2023-04-01 2024-03-31 SC652609 dpl:DistributionCosts 2023-04-01 2024-03-31 SC652609 core:LandBuildings 2023-04-01 2024-03-31 SC652609 core:PlantMachinery 2023-04-01 2024-03-31 SC652609 core:Vehicles 2023-04-01 2024-03-31 SC652609 core:FurnitureFittings 2023-04-01 2024-03-31 SC652609 core:OfficeEquipment 2023-04-01 2024-03-31 SC652609 dpl:AdministrativeExpenses 2023-04-01 2024-03-31 SC652609 core:NetGoodwill 2023-04-01 2024-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 SC652609 dpl:GroupUndertakings 2023-04-01 2024-03-31 SC652609 dpl:ParticipatingInterests 2023-04-01 2024-03-31 SC652609 dpl:GroupUndertakings core:ListedExchangeTraded 2023-04-01 2024-03-31 SC652609 core:ListedExchangeTraded 2023-04-01 2024-03-31 SC652609 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 SC652609 core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 SC652609 core:NetGoodwill 2025-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 SC652609 core:LandBuildings 2025-03-31 SC652609 core:PlantMachinery 2025-03-31 SC652609 core:Vehicles 2025-03-31 SC652609 core:FurnitureFittings 2025-03-31 SC652609 core:OfficeEquipment 2025-03-31 SC652609 core:AfterOneYear 2025-03-31 SC652609 core:WithinOneYear 2025-03-31 SC652609 core:ListedExchangeTraded 2025-03-31 SC652609 core:UnlistedNon-exchangeTraded 2025-03-31 SC652609 core:ShareCapital 2025-03-31 SC652609 core:SharePremium 2025-03-31 SC652609 core:RevaluationReserve 2025-03-31 SC652609 core:OtherReservesSubtotal 2025-03-31 SC652609 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC652609 core:NetGoodwill 2024-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 SC652609 core:LandBuildings 2024-03-31 SC652609 core:PlantMachinery 2024-03-31 SC652609 core:Vehicles 2024-03-31 SC652609 core:FurnitureFittings 2024-03-31 SC652609 core:OfficeEquipment 2024-03-31 SC652609 core:AfterOneYear 2024-03-31 SC652609 core:WithinOneYear 2024-03-31 SC652609 core:ListedExchangeTraded 2024-03-31 SC652609 core:UnlistedNon-exchangeTraded 2024-03-31 SC652609 core:ShareCapital 2024-03-31 SC652609 core:SharePremium 2024-03-31 SC652609 core:RevaluationReserve 2024-03-31 SC652609 core:OtherReservesSubtotal 2024-03-31 SC652609 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC652609 core:NetGoodwill 2023-03-31 SC652609 core:IntangibleAssetsOtherThanGoodwill 2023-03-31 SC652609 core:LandBuildings 2023-03-31 SC652609 core:PlantMachinery 2023-03-31 SC652609 core:Vehicles 2023-03-31 SC652609 core:FurnitureFittings 2023-03-31 SC652609 core:OfficeEquipment 2023-03-31 SC652609 core:AfterOneYear 2023-03-31 SC652609 core:WithinOneYear 2023-03-31 SC652609 core:ListedExchangeTraded 2023-03-31 SC652609 core:UnlistedNon-exchangeTraded 2023-03-31 SC652609 core:ShareCapital 2023-03-31 SC652609 core:SharePremium 2023-03-31 SC652609 core:RevaluationReserve 2023-03-31 SC652609 core:OtherReservesSubtotal 2023-03-31 SC652609 core:RetainedEarningsAccumulatedLosses 2023-03-31 SC652609 core:AfterOneYear 2024-04-01 2025-03-31 SC652609 core:WithinOneYear 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:CostValuation 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 SC652609 core:Non-currentFinancialInstruments core:CostValuation 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-31 SC652609 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-31 SC652609 bus:Director1 2024-04-01 2025-03-31

RA MEDIC LTD

Registered Number
SC652609
(Scotland)

Unaudited Financial Statements for the Year ended
31 March 2025

RA MEDIC LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Director | AHMED, Raza Husan

Registered Address | 4 Monteith Ave
| Stirling
| FK7 9BJ

Registered Number | SC652609 (Scotland)

RA MEDIC LTD
Balance Sheet as at
31 March 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |
Debtors | 3 | 23,785 |  |  |  | 17,425 |  |
Cash at bank and on hand |  | 541 |  |  |  | 8 |  |
|  | 24,326 |  |  |  | 17,433 |  |
Creditors amounts falling due within one year | 4 | (5,410) |  |  |  | (10,210) |  |
Net current assets (liabilities) |  |  |  | 18,916 |  |  |  | 7,223
Total assets less current liabilities |  |  |  | 18,916 |  |  |  | 7,223
Creditors amounts falling due after one year | 5 |  |  | (2,353) |  |  |  | (7,220)
Net assets |  |  |  | 16,563 |  |  |  | 3
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1 |  |  |  | 1
Profit and loss account |  |  |  | 16,562 |  |  |  | 2
Shareholders' funds |  |  |  | 16,563 |  |  |  | 3

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 24 December 2025, and are signed on its behalf by:
AHMED, Raza Husan Director Registered Company No. SC652609

RA MEDIC LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Financial instruments
--- | ---
| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortized cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortized. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors, loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortized. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortized cost using the effective interest method.

| Share capital
--- | ---
| Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 1 |  | 1

3. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | 23,785 |  | 17,425
| Total | 23,785 |  | 17,425

4. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Bank borrowings and overdrafts | 4,750 |  | 4,750
| Taxation and social security | - |  | 4,140
| Accrued liabilities and deferred income | 660 |  | 1,320
| Total | 5,410 |  | 10,210

5. | Creditors: amounts due after one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Bank borrowings and overdrafts | 2,353 |  | 7,220
| Total | 2,353 |  | 7,220

| Included in bank borrowings less than one year and more than one year is an amount of £7,104 (2024 : £11,971) related to the bounceback loan.

6. | Related party transactions
--- | ---
| Included in other debtors is an amount of £23,785 (2024 : £17,425) due from the director.